Mumbai, February 08th, 2025: Alkem Laboratories Ltd. (BSE: 539523, NSE: ALKEM, “Alkem” and its subsidiaries), a leading Indian pharmaceutical company, today announced two strategic acquisitions to further cement its position in the domestic market. Alkem has signed a binding term sheet to acquire 100% stake of Adroit Biomed Ltd., a pharmaceutical company with focus on […]
The post Alkem Laboratories Expands with Strategic Acquisitions in Skincare and Medical Devices first appeared on Business News Week.